The Development of Lipid-lowering Drug Screen Mode Based on Saccharomyces Cerevisiae

TAN Yong-lin,XU Dong-bin,ZHANG Da-li,SHI Hui-li,CHEN Jia-Kuan,HUO Ke-ke
DOI: https://doi.org/10.3969/j.issn.0427-7104.2005.04.003
2005-01-01
Abstract:Both Saccharomyces cerevisiae and Homo sapiens are same in most part of sterol biosynthesis pathway except Desmosterol become ergosterol in S.cerevisiae and the counterpart in human is cholesterol.Using the gene-disrupted S.cerevisiae strains,we combined different deletions by yeast sporulation,mating and tetrad dissection,and the growth status of the deletion strains growing in drug-containing medium were tested using mevinolin and gemfibrozil as the positive control drugs.Compound ethyl linoleate,Oenothera biennis oil and some Chinese traditional medicine such as haw and Salvia miltiorrhiza Bunge were tested by this drug screen model.The results of the work were analyzed and discussed.
What problem does this paper attempt to address?